Role of environmental toxins in endemic (Balkan) nephropathy

被引:116
作者
Grollman, Arthur P. [1 ]
Jelakovic, Bojan
机构
[1] SUNY Stony Brook, Dept Pharmacol Sci, Biol Chem Lab, Stony Brook, NY 11794 USA
[2] Univ Zagreb, Sch Med, Dept Nephrol & Arterial Hypertens, Zagreb 41001, Croatia
[3] Univ Hosp Ctr, Zagreb, Croatia
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 18卷 / 11期
关键词
D O I
10.1681/ASN.2007050537
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
An international symposium, held in Zagreb, Croatia, in October 2006, brought together basic scientists and clinical investigators engaged in research on endemic (Balkan) nephropathy, a chronic renal tubulointerstitial disease of previously unknown cause that often is accompanied by upper urinary tract urothelial cancer. Although this disease is endemic in rural areas of Bosnia, Bulgaria, Croatia, Romania, and Serbia, a similar clinical entity occurs throughout Europe, Asia, and North America. Recent advances in the understanding of endemic nephropathy now favor the causative role of aristolochic acid over the ubiquitous mycotoxin known as ochratoxin A. Specifically, aristolactam-DNA adducts have been found in renal tissues and urothelial cancers of affected patients. A "signature" p53 mutation in the upper urothelial cancer associated with this disease provides evidence of long-term exposure to aristolochic acid. In addition, the renal pathophysiology and histopathology observed in endemic nephropathy most closely resemble the entity known as aristolochic acid nephropathy. Public health authorities in countries harboring this disease are encouraged to reduce the potential for dietary exposure to Aristolochia clematitis.
引用
收藏
页码:2817 / 2823
页数:7
相关论文
共 43 条
  • [1] Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
    Arlt, VM
    Stiborova, M
    Schmeiser, HH
    [J]. MUTAGENESIS, 2002, 17 (04) : 265 - 277
  • [2] Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers
    Batuman, V
    [J]. KIDNEY INTERNATIONAL, 2006, 69 (04) : 644 - 646
  • [3] BUKVIC D, 2004, ENDEMIC NEPHROPATHY, P15
  • [4] Cavin C, 2007, TOXICOL SCI, V96, P30, DOI [10.1093/toxscikfl169, 10.1093/toxsci/kfl169]
  • [5] Ochratoxin A: Its cancer risk and potential for exposure
    Clark, HA
    Snedeker, SM
    [J]. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2006, 9 (2-3): : 265 - 296
  • [6] Aristolochic acid and 'Chinese herbs nephropathy' - A review of the evidence to date
    Cosyns, JP
    [J]. DRUG SAFETY, 2003, 26 (01) : 33 - 48
  • [7] CHINESE HERBS NEPHROPATHY - A CLUE TO BALKAN ENDEMIC NEPHROPATHY
    COSYNS, JP
    JADOUL, M
    SQUIFFLET, JP
    DEPLAEN, JF
    FERLUGA, D
    DESTRIHOU, CV
    [J]. KIDNEY INTERNATIONAL, 1994, 45 (06) : 1680 - 1688
  • [8] DAWSON WR, 1927, PHARM J PHARM, P396
  • [9] DJUKANOVIC L, 2003, CLIN NEPHROTOXINS, P587
  • [10] Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis
    Dong, Huan
    Suzuki, Naomi
    Torres, Maria C.
    Bonala, Radha R.
    Johnson, Francis
    Grollman, Arthur P.
    Shibutani, Shinya
    [J]. DRUG METABOLISM AND DISPOSITION, 2006, 34 (07) : 1122 - 1127